COSMOS HEALTH NEW DL-01 Market Cap ($14.90 Million)
Market Cap & Net Worth: COSMOS HEALTH NEW DL-01 (V67A)
COSMOS HEALTH NEW DL-01 market cap. COSMOS HEALTH NEW DL-01 (F:V67A) has a market capitalization of $14.90 Million (€12.75 Million) as of November 3, 2026. Listed on the F stock exchange, this Germany-based company holds position #25860 globally and #2214 in its home market, demonstrating a 22.57% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying COSMOS HEALTH NEW DL-01's stock price €0.27 by its total outstanding shares 52331231 (52.33 Million). Also see V67A cash generation efficiency for how efficiently the company converts equity into cash flow.
COSMOS HEALTH NEW DL-01 Market Cap History (2022–2026)
COSMOS HEALTH NEW DL-01 market cap history from 2022 to 2026. Data shows change from $257.69 Million to $16.48 Million (-61.68% CAGR). Check COSMOS HEALTH NEW DL-01 stock price for real-time trading data and today's change.
COSMOS HEALTH NEW DL-01 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how COSMOS HEALTH NEW DL-01's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore COSMOS HEALTH NEW DL-01 net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.39x
COSMOS HEALTH NEW DL-01's market cap is 0.39 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $257.69 Million | $50.35 Million | -$13.83 Million | 5.12x | N/A |
| 2023 | $81.37 Million | $53.38 Million | -$18.54 Million | 1.52x | N/A |
| 2024 | $39.13 Million | $54.43 Million | -$16.18 Million | 0.72x | N/A |
| 2025 | $25.15 Million | $65.27 Million | -$19.14 Million | 0.39x | N/A |
Competitor Companies of V67A by Market Capitalization
Companies near COSMOS HEALTH NEW DL-01 in the global market cap rankings as of November 3, 2026. Also see COSMOS HEALTH NEW DL-01 balance sheet assets for a full breakdown of the balance sheet.
Key companies related to COSMOS HEALTH NEW DL-01 by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #247 globally with a market cap of $101.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #450 globally with a market cap of $61.32 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #625 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1151 globally with a market cap of $22.38 Billion USD ( AU$31.63 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #247 | McKesson Corporation | NYSE:MCK | $101.38 Billion | $998.38 |
| #450 | Cencora Inc. | NYSE:COR | $61.32 Billion | $337.84 |
| #625 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $254.33 |
| #1151 | Sigma Healthcare Ltd | AU:SIG | $22.38 Billion | AU$2.74 |
Market Capitalization of COSMOS HEALTH NEW DL-01 (2022–2026)
Market capitalization of COSMOS HEALTH NEW DL-01 from 2022 to today. Between 2022 and today, COSMOS HEALTH NEW DL-01's market cap moved from $257.69 Million to $ 16.48 Million, with a yearly change of -61.68%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €16.48 Million | -34.45% |
| 2025 | €25.15 Million | -35.73% |
| 2024 | €39.13 Million | -51.92% |
| 2023 | €81.37 Million | -68.42% |
| 2022 | €257.69 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of COSMOS HEALTH NEW DL-01 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $14.90 Million USD |
| MoneyControl | $14.90 Million USD |
| MarketWatch | $14.90 Million USD |
| marketcap.company | $14.90 Million USD |
| Reuters | $14.90 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About COSMOS HEALTH NEW DL-01
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It als… Read more